Notably, the mutation rates of TP53 and PIK3R1—genes strongly linked to poor prognosis in BC—were significantly higher in the ASCL1-high group, suggesting a potential association between elevated ASCL1 expression and BC progression. Here, TP53 is linked to breast cancer.